Cellply
Cellply
DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.
About
What does Cellply do?
Cellply is a Bologna-based DeepTech startup focused on developing advanced analytical tools for the deep characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. Their flagship product, VivaCyte®, is an automated analytical system that utilizes patented microfluidic technology, AI-powered image analysis, and dedicated software to enable rapid discovery and process development of cell therapies at single-cell resolution. The company aims to accelerate the adopti…
What is Cellply's revenue?
StartupHub estimates Cellply's annual revenue at $2.7M (range $1.5M to $9.6M, 68% confidence), based on comparable companies in the sector.
What is Cellply's valuation?
StartupHub estimates Cellply's effective valuation at $28.9M (range $17.9M to $42.9M, 24% confidence), based on comparable companies in the sector.
How much funding has Cellply raised?
Cellply has raised a total of $7M in funding. The most recent round on record is Funding Round.
Where is Cellply headquartered?
Cellply is headquartered in Bologna, Italy.
When was Cellply founded?
Cellply was founded in 2013.
What industry does Cellply operate in?
Cellply operates in Biotechnology, HealthTech, Artificial Intelligence, Medical Devices.
How many employees does Cellply have?
Cellply has approximately 25 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.